glp-1 weight loss cost
Shifts US Toward $1 Trillion With Prescription Weight Loss
A 67% jump in Medicare Part D weight-loss claim volume between 2023 and 2025 shows prescription weight-loss drugs are pushing the program toward a $1 trillion spend. As seniors adopt semaglutide and tirzepatide, per-patient costs climb to about $850 annually, inflating overall drug budgets. Medical Disclaimer: This article is for